Skip to main content

Table 3 ORs and 95% Cls for quartiles of dietary nutrients intake with risk of cervical intraepithelial neoplasia grades 2 and above among 2304 women in the studya

From: Dietary nutrient intake related to higher grade cervical intraepithelial neoplasia risk: a Chinese population-based study

 

Quartiles of dietary nutrientsb

Q1

Q2

Q3

Q4

P-trendc

Folate

     

 Median intake (μg/day)

297

381

488

764

 

 No. of cases

75

57

49

56

 

 Model 1

1.35 (0.93–1.97)

1.04 (0.70–1.54)

0.85 (0.56–1.28)

1.00 (reference)

< 0.001

 Model 2

1.49 (1.01–2.21)

1.08 (0.72–1.62)

0.89 (0.58–1.35)

1.00 (reference)

< 0.001

 Model 3

1.55 (1.03–2.33)

1.18 (0.77–1.79)

0.94 (0.61–1.46)

1.00 (reference)

0.008

Vitamin B1

     

 Median intake (mg/day)

1.1

1.4

1.9

2.7

 

 No. of cases

72

72

35

58

 

 Model 1

1.24 (0.84–1.82)

1.41 (0.96–2.06)

0.59 (0.39–0.90)

1.00 (reference)

< 0.001

 Model 2

1.29 (0.86–1.93)

1.34 (0.90–1.99)

0.55 (0.36–0.84)

1.00 (reference)

< 0.001

 Model 3

1.49 (0.97–2.28)

1.34 (0.89–2.04)

0.56 (0.36–0.87)

1.00 (reference)

0.017

Vitamin B2

     

 Median intake (mg/day)

1.1

1.4

1.8

2.7

 

 No. of cases

62

63

51

61

 

 Model 1

0.95 (0.65–1.39)

1.07 (0.73–1.57)

0.83 (0.56–1.23)

1.00 (reference)

< 0.001

 Model 2

1.07 (0.72–1.58)

1.12 (0.75–1.66)

0.92 (0.61–1.38)

1.00 (reference)

< 0.001

 Model 3

1.18 (0.78–1.77)

1.11 (0.73–1.68)

0.96 (0.63–1.47)

1.00 (reference)

0.011

Vitamin B6

     

 Median intake (mg/day)

1.7

2.1

2.6

3.9

 

 No. of cases

69

65

47

56

 

 Model 1

1.27 (0.87–1.86)

1.13 (0.77–1.66)

0.83 (0.55–1.25)

1.00 (reference)

< 0.001

 Model 2

1.42 (0.96–2.11)

1.18 (0.79–1.75)

0.87 (0.57–1.32)

1.00 (reference)

< 0.001

 Model 3

1.63 (1.08–2.46)

1.33 (0.88–2.01)

0.93 (0.60–1.44)

1.00 (reference)

0.002

Vitamin C

     

 Median intake (mg/day)

46.0

62.8

86.9

138.9

 

 No. of cases

73

56

57

51

 

 Model 1

1.44 (0.98–2.11)

1.13 (0.76–1.70)

1.14 (0.76–1.71)

1.00 (reference)

< 0.001

 Model 2

1.56 (1.05–2.33)

1.16 (0.76–1.76)

1.15 (0.76–1.75)

1.00 (reference)

< 0.001

 Model 3

1.59 (1.05–2.42)

1.16 (0.75–1.79)

1.11 (0.72–1.71)

1.00 (reference)

0.008

Vitamin E

     

 Median intake (mg/day)

4.4

8.8

10.8

21.7

 

 No. of cases

50

67

59

61

 

 Model 1

0.76 (0.51–1.13)

1.03 (0.71–1.50)

1.02 (0.69–1.50)

1.00 (reference)

< 0.001

 Model 2

0.92 (0.61–1.40)

1.13 (0.77–1.66)

1.08 (0.72–1.60)

1.00 (reference)

< 0.001

 Model 3

0.93 (0.60–1.43)

1.29 (0.86–1.93)

1.04 (0.69–1.58)

1.00 (reference)

0.011

Vitamin K

     

 Median intake (μg/day)

133.0

194.0

285.0

534.0

 

 No. of cases

61

71

51

54

 

 Model 1

1.12 (0.77–1.65)

1.42 (0.96–2.10)

1.01 (0.68–1.50)

1.00 (reference)

< 0.001

 Model 2

1.20 (0.81–1.79)

1.53 (1.02–2.29)

1.05 (0.70–1.58)

1.00 (reference)

< 0.001

 Model 3

1.30 (0.86–1.98)

1.60 (1.05–2.44)

1.24 (0.81–1.89)

1.00 (reference)

0.009

Niacin

     

 Median intake (mg/day)

17.7

21.6

27.9

42.8

 

 No. of cases

68

60

54

55

 

 Model 1

1.30 (0.88–1.92)

1.08 (0.73–1.59)

1.02 (0.69–1.51)

1.00 (reference)

< 0.001

 Model 2

1.40 (0.94–2.09)

1.14 (0.76–1.70)

0.98 (0.65–1.47)

1.00 (reference)

< 0.001

 Model 3

1.65 (1.08–2.51)

1.32 (0.87–2.01)

1.09 (0.71–1.66)

1.00 (reference)

0.009

Dietary fiber

     

 Median intake (g/day)

27.4

34.5

43.7

63.2

 

 No. of cases

68

64

49

56

 

 Model 1

1.23 (0.84–1.81)

1.18 (0.80–1.73)

0.84 (0.56–1.26)

1.00 (reference)

< 0.001

 Model 2

1.31 (0.88–1.95)

1.18 (0.79–1.76)

0.80 (0.53–1.22)

1.00 (reference)

< 0.001

 Model 3

1.50 (0.99–2.27)

1.16 (0.76–1.76)

0.87 (0.56–1.34)

1.00 (reference)

0.009

  1. CIN1, cervical intraepithelial neoplasia grade 1; CI confidence interval
  2. aValues are n or ORs (95% CIs) obtained from logistic regression analysis, based on the highest intake group as the reference, unless otherwise indicated
  3. bModel 1: odds ratios unadjusted; Model 2: odds ratios adjusted for age, education years, annual family salary, smoker, age at menarche, menopause status, IUD use, years of IUD use, Sexual activity in menstrual period, had gynecologic surgery, had vaginitis; Model 3: additionally odds ratios adjusted for high-risk HPV, SCJ visibility, vaginal pH
  4. cP values for differences between groups were obtained from the Bonferroni correction test for categoric variables